Menu Back toSession-10-Advanced-Technologies

Pharmacovigilance and Risk Management Strategies Conference

Session 9: Advanced Technologies

    Session Chair(s)
      Stephen  Knowles, MD, MRCP

      Stephen Knowles, MD, MRCP

      • Vice President, Drug Safety and Pharmacovigilance
      • Halozyme Therapeutics, United States
    The use of advanced technologies in the management of chronic diseases and monitoring patients in clinical trials is increasing. For example, the use of mobile apps to aid the control of diabetes, the use of wearable technologies to monitor patient sleep and activity during clinical trials, and implantable biosensors which allow continuous monitoring of body chemicals. This session will bring scientific expert and patient perspectives together in a discussion of these new technologies and the impact they are having, and will have, on patient monitoring and patient experience.
      Gary K. Zammit, PhD, MS

      The Use of Wearable Technologies in Clinical Trials to Monitor Movement and Sleep/Wake Patterns

      Gary K. Zammit, PhD, MS

      • President and CEO
      • Clinilabs Drug Development Corporation, United States
      Sara  Loud, MBA, MS

      Breakthrough or Big Brother? Thoughts on Advanced Technologies and Data Sharing from the Multiple Sclerosis Community

      Sara Loud, MBA, MS

      • Chief Operating Officer
      • Accelerated Cure Project, United States